185 related articles for article (PubMed ID: 37558702)
1. Multiomics of three hematological malignancies in a patient reveal their origin from clonal hematopoietic stem cells.
Mayeur S; Molitor A; Miguet L; Rigolot L; Naegely L; Stemmelen T; Meyer S; Toussaint E; Vallat L; Eischen A; Chenard MP; Tavian M; Bahram S; Carapito R; Nicolae A
Blood Cancer J; 2023 Aug; 13(1):118. PubMed ID: 37558702
[No Abstract] [Full Text] [Related]
2. To portray clonal evolution in blood cancer, count your stem cells.
Lyne AM; Laplane L; Perié L
Blood; 2021 Apr; 137(14):1862-1870. PubMed ID: 33512426
[TBL] [Abstract][Full Text] [Related]
3. 'CHIP'ping away at clonal hematopoiesis.
Link DC; Walter MJ
Leukemia; 2016 Aug; 30(8):1633-5. PubMed ID: 27311932
[No Abstract] [Full Text] [Related]
4. Transition to homozygosity does not appear to provide a clonal advantage to hematopoietic progenitors carrying mutations in TET2.
Schaub FX; Lehmann T; Looser R; Hao-Shen H; Tichelli A; Skoda RC
Blood; 2011 Feb; 117(6):2075-6. PubMed ID: 21310937
[No Abstract] [Full Text] [Related]
5. Clonal hematopoiesis: Molecular basis and clinical relevance.
Kunimoto H; Nakajima H
Leuk Res; 2020 Nov; 98():106457. PubMed ID: 33010619
[TBL] [Abstract][Full Text] [Related]
6. [Aberrant cytosine hydroxymethylation in hematologic malignancies].
Sakata-Yanagimoto M; Chiba S
Rinsho Ketsueki; 2013 May; 54(5):423-30. PubMed ID: 23727679
[No Abstract] [Full Text] [Related]
7. Clonal Hematopoiesis of Indeterminate Potential in Patients with Solid Tumor Malignancies.
Marshall CH; Gondek LP; Luo J; Antonarakis ES
Cancer Res; 2022 Nov; 82(22):4107-4113. PubMed ID: 36040522
[TBL] [Abstract][Full Text] [Related]
8. Distinction of lymphoid and myeloid clonal hematopoiesis.
Niroula A; Sekar A; Murakami MA; Trinder M; Agrawal M; Wong WJ; Bick AG; Uddin MM; Gibson CJ; Griffin GK; Honigberg MC; Zekavat SM; Paruchuri K; Natarajan P; Ebert BL
Nat Med; 2021 Nov; 27(11):1921-1927. PubMed ID: 34663986
[TBL] [Abstract][Full Text] [Related]
9. Clonal hematopoiesis: Molecular and clinical implications.
Kusne Y; Xie Z; Patnaik MM
Leuk Res; 2022 Feb; 113():106787. PubMed ID: 35091334
[TBL] [Abstract][Full Text] [Related]
10. Hematological malignancies: disease pathophysiology of leukemic stem cells.
Ramdass B; Chowdhary A; Koka PS
J Stem Cells; 2013; 8(3-4):151-87. PubMed ID: 24699024
[TBL] [Abstract][Full Text] [Related]
11. The roles of Polycomb group proteins in hematopoietic stem cells and hematological malignancies.
Takamatsu-Ichihara E; Kitabayashi I
Int J Hematol; 2016 Jun; 103(6):634-42. PubMed ID: 27086351
[TBL] [Abstract][Full Text] [Related]
12. [In cauda venenum or the importance of TET(2)].
Mercher T; Quivoron C; Couronné L; Vainchenker W; Bastard C; Bernard OA
Med Sci (Paris); 2011 Dec; 27(12):1064-6. PubMed ID: 22192742
[No Abstract] [Full Text] [Related]
13. p53 involvement in clonal hematopoiesis of indeterminate potential.
Chen S; Liu Y
Curr Opin Hematol; 2019 Jul; 26(4):235-240. PubMed ID: 31045645
[TBL] [Abstract][Full Text] [Related]
14. CHIP: is clonal hematopoiesis a surrogate for aging and other disease?
Gondek LP
Hematology Am Soc Hematol Educ Program; 2021 Dec; 2021(1):384-389. PubMed ID: 34889429
[TBL] [Abstract][Full Text] [Related]
15. Clonal Hematopoiesis and Evolution to Hematopoietic Malignancies.
Bowman RL; Busque L; Levine RL
Cell Stem Cell; 2018 Feb; 22(2):157-170. PubMed ID: 29395053
[TBL] [Abstract][Full Text] [Related]
16. Clonal Hematopoiesis and Premalignant Diseases.
Kaner J; Desai P; Mencia-Trinchant N; Guzman ML; Roboz GJ; Hassane DC
Cold Spring Harb Perspect Med; 2020 Apr; 10(4):. PubMed ID: 31615870
[TBL] [Abstract][Full Text] [Related]
17. Increased general predisposition to cancer but not to specific neoplasms of the hematopoietic system in children with hematological neoplasms: a hypothesis.
Roganovic J; Radojcic-Badovinac A
Acta Haematol; 2000; 103(3):172-4. PubMed ID: 10940658
[No Abstract] [Full Text] [Related]
18. Expression patterns of costimulatory molecules on cells derived from human hematological malignancies.
Zheng Z; Takahashi M; Aoki S; Toba K; Liu A; Osman Y; Takahashi H; Tsukada N; Suzuki N; Nikkuni K; Furukawa T; Koike T; Aizawa Y
J Exp Clin Cancer Res; 1998 Sep; 17(3):251-8. PubMed ID: 9894758
[TBL] [Abstract][Full Text] [Related]
19. Myeloproliferative Neoplasms: The Long Wait for JAK2-Mutant Clone Expansion.
Luque Paz D; Ashcroft P; Skoda RC
Cell Stem Cell; 2021 Mar; 28(3):359-361. PubMed ID: 33667352
[TBL] [Abstract][Full Text] [Related]
20. Deletion of Tet2 in mice leads to dysregulated hematopoietic stem cells and subsequent development of myeloid malignancies.
Li Z; Cai X; Cai CL; Wang J; Zhang W; Petersen BE; Yang FC; Xu M
Blood; 2011 Oct; 118(17):4509-18. PubMed ID: 21803851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
